Ondansetron and Jevtana drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ondansetron (ondansetron) and Jevtana (cabazitaxel). Common drug interactions include cardiac failure among females and necrotising retinitis among males.

The phase IV clinical study analyzes what interactions people have when they take Ondansetron and Jevtana. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

What is Jevtana?

Jevtana has active ingredients of cabazitaxel. eHealthMe is studying from 1,811 Jevtana users. Check the latest studies of Jevtana.



On Jul, 12, 2026

48 people who take Ondansetron and Jevtana together, and have interactions are studied.

Ondansetron and Jevtana drug interactions.

What are the common drug interactions of Ondansetron and Jevtana, by gender? *:

female:

  1. Cardiac failure
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Drug hypersensitivity
  4. Hypertension (high blood pressure)
  5. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Psoriasis (immune-mediated disease that affects the skin)
  7. Stress
  8. Sudden death
  9. Visual impairment
  10. Accidental exposure

male:

  1. Necrotising retinitis (life threatening infection of retina)
  2. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  3. Visual field defect
  4. Visual impairment
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Subdural haematoma (blood collects between the skull and the surface of the brain)
  8. Feeling hot
  9. Asthenia (weakness)
  10. Diarrhoea

What are the common drug interactions of Ondansetron and Jevtana, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Drug hypersensitivity
  3. Hypertension (high blood pressure)
  4. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Stress
  7. Sudden death
  8. Visual impairment
  9. Accidental exposure
  10. Cardiac failure

50-59:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Cellulitis (infection under the skin)
  3. Osteomyelitis (infection of bone)

60+:

  1. Necrotising retinitis (life threatening infection of retina)
  2. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  3. Visual field defect
  4. Visual impairment
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Subdural haematoma (blood collects between the skull and the surface of the brain)
  8. Feeling hot
  9. Asthenia (weakness)
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Prostate Cancer: 32 people, 66.67%
  2. High Blood Pressure: 14 people, 29.17%
  3. Prostate Cancer Metastatic: 7 people, 14.58%
  4. Stress And Anxiety: 3 people, 6.25%
  5. Pain: 3 people, 6.25%
  6. Constipation: 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron and Jevtana?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ondansetron and Jevtana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Jevtana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ondansetron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jevtana and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron and cabazitaxel (the active ingredients of Ondansetron and Jevtana, respectively), and Ondansetron and Jevtana (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: